Smiths Medical will introduce several innovative new products at the upcoming American Society of Anesthesiologists annual meeting in Boston, Massachusetts, which will take place between 21 and 23 October.
The new products include Invasive Blood Pressure Monitoring System meets the challenging needs of critical patients with a sophisticated product that helps clinicians focus on patient care.
The aerFree Airway Management System is the first FDA-cleared external negative pressure aid. It’s a non-invasive, comfortable and easy-to-use airway device utilizing aer+™ technology, which is the application of negative pressure to a patient’s neck above the upper airway to support the patency of that airway during medical and surgical procedures requiring mild to moderate sedation.
The CADD®-Solis Ambulatory Infusion Pump now includes wireless communication to and from PharmGuard® Server software, allowing clinicians to securely deploy software updates, remotely manage pump performance, track pump locations, and download infusion data reports.
These new products are adding to the Smiths Medical portfolio of well-recognized and trusted devices that anesthesiologists use through all phases of their patients’ care, including CADD, Jelco, BCI, Deltec, Level 1, Medex, Pneupac, and Portex.
In addition, Smiths Medical will be hosting a symposium on Advancements in Enhanced Recovery After Surgery (ERAS) Initiatives on Sunday, October 22 from 7:00-9:00pm at the Westin Boston Waterfront hotel where industry experts will provide tips and information on implementing and sustaining ERAS initiatives.
ERAS is a clinical pathway for perioperative care, recommending an evidence-based bundle of therapies and interventions, including regional anesthesia and multimodal analgesia, normothermia maintenance, goal-directed fluid therapy, early mobilization, early patient engagement, and preoperative preparation for surgery.
ERAS protocols are implemented by a multidisciplinary perioperative care team, including anesthesiologists, surgeons and nursing. ERAS has been shown to improve clinical outcomes, reduce complications, improve patient experience and reduce length of stay, readmissions and healthcare costs.